Mar 27, 2025 3DHEALS is kicking off its first in-person/hybrid event in 2025 in San Francisco, welcoming investors, entrepreneurs, and innovators in the space. The healthcare industry is transforming, driven by 3D printing and bioprinting technologies redefining patient care. This exclusive in-person event offers an opportunity to explore the latest advancements in custom prosthetics, implants, bioprinted tissues, and scaffolds. Engage with top medical professionals, engineers, and industry pioneers in charge of this rapidly growing sector. For investors, this event is a gateway to high-growth opportunities in healthcare and advanced manufacturing. With global demand for personalized medical solutions rising, 3D printing is set to disrupt traditional supply chains and unlock new revenue streams. Connect with startup founders, industry executives, and R&D leaders driving the commercialization of these technologies. Whether you’re looking to fund the next breakthrough or gain strategic insights into this expanding market, this is an event you won’t want to miss. Secure your place today.
Time/Dates: March 27th, 2025, 5:30 PM – 8:00 PM PST
Location: K&L Gates LLP, 4 Embarcadero Ctr, San Francisco, CA 94111
Agenda:
5:30-6:00 Registration/Networking
6:00-7:20 PM Presentations (speakers to be announced)
7:20-8:00 PM Networking
Apply to speak or sponsor the event: info@3dheals.com
Subscribe here to receive event emails.
Virtual Event Registration Link Coming soon!
Speakers:
Josh Mikulich
Implants & medical technologies sales leader with an emphasis in spinal endoscopy, previously focused on open spine procedures, joint reconstruction, thoracic oncology, and biologics. Currently employed with Arthrex in the spinal endoscopy division. Spinal endoscopy is the most minimally invasive surgical procedure for neural decompression surgery.
Formerly employed with Anatomics as Senior Product Specialist with work involving groundbreaking patient-specific implants mostly for oncology use.
Bhushan Mahadik
Dr. Mahadik received his PhD in Chemical and Biomolecule Engineering at the University of Illinois at Urbana Champaign. His expertise is in the field of tissue engineering, stem cell biology and 3D printing. He was the Assistant Director at the NIH Center for Engineering Complex Tissues (CECT) at the University of Maryland that focused on novel applications of 3D printing and bioreactor technologies. Presently, he is the Director of Research at Prellis Biologics with a focus on using 3D Lymph Node Organoids for the development of new clinically relevant antibodies.
He shares a deep interest in Regenerative Medicine and its applications in the clinical space, ranging from implantable scaffolds for repair and regeneration, to the development and assessment of new therapies using complex in vitro models that recreate native biology.
Rajan Patel
Rajan Patel has over three decades of expertise in driving innovation and advancing commercialization in the healthcare industry. His extensive background encompasses diagnostics, critical care, patient monitoring, and drug delivery technologies. At iO Life Science and iO Life Ventures, he leads the incubation of transformative technologies, overseeing a diverse portfolio of over 20 startups. With significant investment experience and a strong commitment to fostering progress in healthcare, Rajan has played a pivotal role in accelerating the development and commercialization of innovative medical devices. His leadership contributions span renowned companies such as MiniMed, Heartport, Aerogen, M2 Medical, and Cirtec Medical.
As the CEO of Kallisio, Rajan is at the forefront of advancing patient-specific medical devices, addressing key side effects of cancer therapy, such as oral mucositis and other oncology-related complications. Kallisio is dedicated to driving personalized medicine through innovative solutions that enhance treatment precision and improve patient outcomes. These technologies reflect Kallisio’s broader mission to mitigate the adverse effects of cancer therapy, equipping clinicians with tools to deliver precise, effective, and patient-centered care.
Kuan-Lin Chen
Dr. Kuan Lin Chen is an orthopaedic surgeon specializing in hip and knee replacement, as well as complex joint reconstruction following musculoskeletal tumor resection. He also serves as a medical advisor at AMED Ventures. With a background in bioengineering from UC Berkeley, he has a strong foundation in medical device design and innovation. In addition to his clinical and advisory roles, he actively lectures at universities on strategic design thinking in medical technology.
A prolific innovator, Dr. Chen holds several patents and made history as the first resident doctor to license technology from his home academic institution to a company. His passion for bridging clinical needs with cutting-edge solutions led him to his advisory role at a Medtech venture group in the Bay Area, where he provides evidence-based analysis to drive investment and development strategies.
Jesse Courtier
Jesse Courtier, is a Healthcare Investor, Entrepreneur, and Pediatric Radiologist. He is current Managing Partner of Healthcare GT Ventures, a new Venture Studio/Venture Platform. He founded Sira Medical, a venture backed UCSF spinout using Augmented Reality for pre-surgical planning and worked to bring this from idea to FDA 510k cleared application. His interests lie in the application of innovative technologies that positively impact patient lives and improve physician workflow efficiency and well-being.
Moderator:
Dr. Jenny Chen
Dr. Jenny Chen is trained as a neuroradiologist, and founder/CEO of 3DHEALS. Her main interests include next-generation education, 3D printing in the healthcare sector, automated biology, and artificial intelligence. She is an angel investor who invests in Pitch3D companies.
Venue Sponsor:
K&L Gates LLP
Comments